ArticleJournal of thoracic disease2020

Advances in immunotherapy for stage III non-small cell lung cancer: moving immune checkpoint inhibitors to the front lines concurrently with chemoradiotherapy?

Toyoaki Hida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.